NAD+ injections are promoted for benefits like increased energy, sharper mental clarity, cellular repair, and anti-aging support, but human clinical evidence for injectable NAD+ remains limited. This article breaks down what the science actually supports, what stays unproven, and what you should know before considering NAD+ therapy.

Nicotinamide adenine dinucleotide (NAD+) is a coenzyme found in every cell of your body. It plays a central role in energy production, DNA repair, and cellular communication. NAD+ levels naturally decline with age, dropping by roughly 50% between your 20s and 50s [1]. That decline has fueled growing interest in NAD+ therapy as a way to restore what time takes away.

NAD+ has become one of the most talked-about therapies in the wellness and longevity space, with clinics across the country offering injections and IV infusions. Understanding what NAD+ does at the cellular level, how the research stacks up against the marketing claims, and where the FDA stands on these products can help you decide whether NAD+ injections are right for you.

What Is NAD+ and Why Does It Matter?

NAD+ is a coenzyme that helps your cells convert food into usable energy. It works as an electron shuttle in your mitochondria, the structures inside cells that produce adenosine triphosphate (ATP), your body’s primary energy currency [2].

Your body uses NAD+ constantly. Every time a cell produces energy, repairs its DNA, or responds to stress, NAD+ is involved. It cycles between two forms: NAD+ (the oxidized, active form) and NADH (the reduced form), passing electrons back and forth to keep metabolic processes running.

Beyond energy production, NAD+ supports two critical repair systems:

  • PARP enzymes, which detect and fix damaged DNA. When DNA is damaged by UV exposure, oxidative stress, or normal cellular wear, PARPs use NAD+ to fuel the repair process [3].
  • Sirtuins, a family of seven proteins linked to cellular stress response, inflammation regulation, and longevity in animal studies. Sirtuins depend on NAD+ to function and are sometimes called “longevity genes,” though that label oversimplifies their role [4].

As NAD+ levels drop with age, these processes become less efficient. Researchers estimate that NAD+ levels can decline by about 50% between your 20s and 50s, though the rate varies by tissue type and overall health [1]. Research on NAD+ in regenerative medicine has shown these declines correlate with reduced function across multiple organ systems in animal models. That connection is what drives interest in NAD+ supplementation and therapy.

How NAD+ therapy is delivered

NAD+ therapy comes in several forms, each with different trade-offs:

  • IV infusions: Delivered through a vein over one to four hours in a clinical setting. This is the most common format at wellness clinics.
  • Subcutaneous or intramuscular injections: Self-administered or given by a provider in minutes. These are the “NAD+ injections” most people search for.
  • Oral precursors: Supplements like nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) that your body converts into NAD+. These are widely available over the counter. NAD+ precursors are forms of niacin (vitamin B3), a nutrient your body uses to build NAD+.

Injections and IV infusions bypass the gastrointestinal tract, which may allow more NAD+ to reach your bloodstream than oral forms. That said, clinical outcome data comparing injection results to oral forms in humans is limited. No large human trials have shown that one delivery method produces better health outcomes than another [5].

Is NAD+ FDA-Approved?

NAD+ is not FDA-approved for any specific medical indication. Compounded NAD+ injections, the form most clinics offer, are not FDA-approved as a finished drug product. Uses like anti-aging support, energy enhancement, and cognitive improvement are off-label applications without FDA-approved indications. The FDA’s guidance on drug compounding explains the regulatory framework that applies to these products [6].

This distinction matters for safety. Because compounded NAD+ products are not manufactured under the same oversight as FDA-approved drugs, quality can vary between providers.

FDA enforcement and safety signals

In 2025, the FDA issued a Class I recall, its most serious recall category, for compounded NAD+ injectable products from GenoGenix Health due to endotoxin contamination. Endotoxins are bacterial toxins that can cause fever, organ damage, and in severe cases, septic shock when injected [7].

The FDA has also issued guidance reminding compounding pharmacies that ingredients used in sterile compounding must be pharmaceutical-grade and suitable for injection. The agency specifically flagged the use of food-grade NAD+ in injectable products as a safety concern. Food-grade NAD+ is manufactured for oral supplements and does not meet the purity standards required for sterile injectable formulations [8].

None of this means NAD+ injections are inherently dangerous when prepared correctly. It does mean that the source and quality of the product matter, and that regulatory oversight of compounded injectables is less rigorous than for FDA-approved drugs.

What the Research Shows

Human clinical evidence for injectable NAD+ is limited. Most of what we know about NAD+ and its precursors comes from animal studies, cell-based research, and a small number of human trials using oral supplements (not injections). A review of NAD+-boosting compounds in humans found that while supplementation can raise blood NAD+ levels, consistent clinical benefits remain unconfirmed. Cleveland Clinic’s overview of NAD+ supplements similarly notes that “research in this area is still developing.” Here is what the research shows across the most commonly promoted benefit categories.

Energy and mitochondrial function

NAD+ is central to ATP production in your mitochondria. Without sufficient NAD+, the electron transport chain that generates most of your cellular energy runs less efficiently.

Animal studies show that restoring NAD+ levels can improve mitochondrial function and physical endurance in aged mice [9]. In one widely cited study, older mice given NMN (which converts to NAD+) showed endurance improvements comparable to younger animals.

Human data for injectable NAD+ specifically is still emerging. Some small studies and case series suggest IV NAD+ may reduce fatigue, but these lack the control groups and sample sizes needed to draw firm conclusions [10]. The gap between animal evidence and human proof remains significant for this benefit category.

Evidence level: Animal studies are strong. Human evidence for injections is preliminary.

Cognitive function and mental clarity

Preclinical research suggests NAD+ may have neuroprotective effects. In animal models, boosting NAD+ levels has been associated with reduced neuroinflammation and improved cognitive performance in mice with neurodegenerative conditions [11]. The theory is that NAD+ supports mitochondrial function in neurons, which are especially energy-hungry cells.

Some people who receive NAD+ injections report improved focus and mental clarity, but these reports are anecdotal. No controlled human trials have tested whether NAD+ injections improve cognitive function in healthy adults or in people with cognitive decline.

Evidence level: Preclinical data is promising. Human evidence is anecdotal.

DNA repair and cellular aging

PARP enzymes, which depend on NAD+ to function, are your cells’ primary DNA repair system. Animal models have shown that boosting NAD+ levels can extend lifespan and improve markers of cellular aging in mice [12]. No human trials have demonstrated anti-aging effects from NAD+ injections or supplementation.

Evidence level: Strong mechanistic basis. Animal data is supportive. No human proof of anti-aging effects.

Metabolic health

The strongest human evidence in the NAD+ space comes from a 2021 trial published in Science, which showed that oral NMN (a NAD+ precursor) improved muscle insulin sensitivity in prediabetic women over 10 weeks [13]. The study was randomized, double-blind, and placebo-controlled, giving it more weight than most NAD+ research.

This is a meaningful finding, but two caveats apply. First, the study used oral NMN, not injectable NAD+. Second, NMN is a precursor that your body converts to NAD+, not NAD+ itself. Extrapolating results from one compound and delivery method to another requires caution until direct comparison studies are available.

Evidence level: One well-designed human trial (oral NMN). No comparable data for injectable NAD+.

Addiction and withdrawal support

NAD+ therapy for addiction recovery dates to the 1960s, when clinicians used IV NAD+ to support people going through alcohol and opioid withdrawal. Interest has continued, with some clinics offering NAD+ as part of detox protocols. The evidence base remains limited to case reports and small, uncontrolled studies. No large randomized controlled trials (RCTs) have confirmed these effects.

Evidence level: Historical clinical use. Evidence limited to case reports and small studies.

Side Effects and Safety Considerations

NAD+ injections are generally tolerable at standard doses, but they are not risk-free. Understanding the potential side effects can help you and your health care provider decide whether this therapy makes sense for your situation.

Common side effects

The most frequently reported side effects include [14]:

  • Nausea
  • Flushing or warmth
  • Headache
  • Dizziness or lightheadedness
  • Discomfort, redness, or bruising at the injection site

These side effects tend to be dose-dependent and temporary. With IV infusions specifically, infusing too quickly can cause chest tightness, a drop in blood pressure, or a rapid heart rate. Most clinics manage this by slowing the infusion rate. Subcutaneous injections generally produce fewer infusion-related reactions but can still cause local irritation.

Serious considerations

Cancer risk: NAD+ supports cell growth and proliferation broadly, not selectively. Researchers have raised a theoretical concern that boosting NAD+ could accelerate the growth of existing tumors. If you have active cancer or a history of cancer, discuss this with your oncologist before considering NAD+ therapy [14].

Organ stress: Because NAD+ is metabolized by your liver and kidneys, you should use caution if you have severe liver or kidney disease. Long-term safety data for NAD+ injections is not available.

Pregnancy and breastfeeding: NAD+ injections have not been studied during pregnancy or breastfeeding. Most providers recommend avoiding them during this time.

Contamination risk: As noted in the FDA section above, compounded NAD+ products have been subject to recalls for contamination. Quality varies between compounding pharmacies.

Baseline labs to consider before starting

If you are thinking about NAD+ injections, your provider may recommend baseline lab work to check for underlying conditions that could increase your risk of side effects. Relevant tests include:

  • Comprehensive metabolic panel (CMP): Measures kidney function (creatinine, BUN) and liver enzymes (ALT, AST) to help identify organ stress before starting therapy
  • Complete blood count (CBC): Evaluates white blood cell counts and other markers that can flag infection or immune concerns
  • Lipid panel: Provides a baseline for cholesterol and triglycerides, which are relevant if you are using NAD+ for metabolic health goals
  • Basic metabolic panel (BMP): A more focused panel that still covers key kidney function markers and electrolyte balance

These tests do not tell you whether NAD+ will work for you, but they can help your provider identify potential risks before you start.

Key Takeaways

  • NAD+ plays a real role in energy production, DNA repair, and cellular metabolism, but injectable NAD+ has limited human clinical evidence.
  • NAD+ injections are not FDA-approved for any medical indication. Compounded products vary in quality and have been subject to FDA recalls.
  • The strongest human data for NAD+ precursors comes from an oral NMN trial, not from injectable NAD+.
  • Side effects are usually mild, but theoretical concerns exist around cancer risk and organ stress.
  • Baseline lab work (CMP, CBC, lipid panel) can help your provider assess whether NAD+ therapy is appropriate for you.

Frequently Asked Questions

Do NAD+ injections really work?

NAD+ is a real coenzyme with well-established roles in energy production and DNA repair, but human clinical trials on injectable NAD+ are limited. Most supporting evidence comes from animal studies or trials using oral precursors like NMN.

How long do NAD+ shots last?

Effects vary by individual and are not well-studied in controlled trials. Some people report feeling increased energy for several days to a few weeks after an injection, but no clinical research has confirmed how long a single dose affects NAD+ levels or produces noticeable effects.

What is the downside of taking NAD+?

Common side effects include nausea, flushing, and headache. More serious concerns include a theoretical risk that NAD+ could support tumor growth in people with active cancer, and the fact that compounded products may not meet pharmaceutical-grade quality standards.

Is NAD+ like Ozempic?

No. Ozempic (semaglutide) is an FDA-approved GLP-1 receptor agonist with extensive clinical trial data supporting its use for type 2 diabetes and weight management. You can learn more about GLP-1 medications in our guide to compounded semaglutide. NAD+ is a coenzyme with a different mechanism, limited human evidence, and no FDA approval for any indication.

How much do NAD+ injections cost?

NAD+ injection costs typically range from $50 to $200 per injection, depending on the dose and provider. IV infusions tend to cost more, ranging from $250 to $1,000 or more per session. Insurance generally does not cover NAD+ therapy because it is not FDA-approved.

How to Get Started

If you are interested in learning more about NAD+ therapy, start by talking with a health care provider who can review your health history and help you weigh the potential benefits against the current evidence gaps. Your provider can order baseline lab work to make sure NAD+ therapy is appropriate given your kidney function, liver health, and overall metabolic profile.

When choosing a provider, look for these indicators of quality:

  • Pharmaceutical-grade NAD+ sourced from a licensed compounding pharmacy (not food-grade ingredients)
  • Medical oversight during IV infusions or injection protocols
  • Transparent information about dosing, ingredient sourcing, and the compounding pharmacy used
  • Willingness to discuss limitations in the current evidence base

For more information about NAD+ therapy options, visit the NAD+ treatments page on Testing.com. You can also browse our full library of treatment guides covering GLP-1 medications, sermorelin, and other peptide therapies.

Sources

See More